Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 May;37(5):342–347. doi: 10.1136/jmg.37.5.342

Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer

B I Sigbjornsdottir 1, G Ragnarsson 1, B A Agnarsson 1, C Huiping 1, R B Barkardottir 1, V Egilsson 1, S Ingvarsson 1
PMCID: PMC1734587  PMID: 10807692

Abstract

Chromosomal losses involving the short arm of chromosome 8 are frequent in a variety of tumour types, including breast cancer, suggesting the presence of one or more tumour suppressor genes in this region. In this study, we have used 11 microsatellite markers to analyse loss of heterozygosity (LOH) at chromosome 8p in 151 sporadic breast tumours and 50 tumours from subjects carrying the BRCA2 999del5 mutation. Fifty percent of sporadic tumours compared to 78% of BRCA2 linked tumours exhibit LOH at one or more markers at 8p showing that chromosome 8p alterations in breast tumours from BRCA2 999del5 carriers are more pronounced than in sporadic breast tumours. The pattern of LOH is different in the two groups and a higher proportion of BRCA2 tumours have LOH in a large region of chromosome 8p. In the total patient material, LOH of 8p is associated with LOH at other chromosome regions, for example, 1p, 3p, 6q, 7q, 9p, 11p, 13q, 17p, and 20q, but no association is found between LOH at 8p and chromosome regions 11q, 16q, 17q, and 18q. Furthermore, an association is detected between LOH at 8p and positive node status, large tumour size, aneuploidy, and high S phase fraction. Breast cancer patients with LOH at chromosome 8p have a worse prognosis than patients without this defect. Multivariate analysis suggests that LOH at 8p is an independent prognostic factor. We conclude that chromosome 8p carries a tumour suppressor gene or genes, the loss of which results in growth advantage of breast tumour cells, especially in carriers of the BRCA2 999del5 mutation.


Keywords: chromosome 8; BRCA2; LOH; breast cancer

Full Text

The Full Text of this article is available as a PDF (164.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott D. W., Freeman M. L., Holt J. T. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst. 1998 Jul 1;90(13):978–985. doi: 10.1093/jnci/90.13.978. [DOI] [PubMed] [Google Scholar]
  2. Agnarsson B. A., Jonasson J. G., Björnsdottir I. B., Barkardottir R. B., Egilsson V., Sigurdsson H. Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat. 1998 Jan;47(2):121–127. doi: 10.1023/a:1005853022804. [DOI] [PubMed] [Google Scholar]
  3. Anbazhagan R., Fujii H., Gabrielson E. Allelic loss of chromosomal arm 8p in breast cancer progression. Am J Pathol. 1998 Mar;152(3):815–819. [PMC free article] [PubMed] [Google Scholar]
  4. Barkardóttir R. B., Arason A., Egilsson V., Gudmundsson J., Jónasdóttir A., Jóhannesdóttir G. Chromosome 17q-linkage seems to be infrequent in Icelandic families at risk of breast cancer. Acta Oncol. 1995;34(5):657–662. doi: 10.3109/02841869509094044. [DOI] [PubMed] [Google Scholar]
  5. Bergthorsson J. T., Johannsdottir J., Jonasdottir A., Eiriksdottir G., Egilsson V., Ingvarsson S., Barkardottir R. B., Arason A. Chromosome imbalance at the 3p14 region in human breast tumours: high frequency in patients with inherited predisposition due to BRCA2. Eur J Cancer. 1998 Jan;34(1):142–147. doi: 10.1016/s0959-8049(97)00339-0. [DOI] [PubMed] [Google Scholar]
  6. Bova G. S., Carter B. S., Bussemakers M. J., Emi M., Fujiwara Y., Kyprianou N., Jacobs S. C., Robinson J. C., Epstein J. I., Walsh P. C. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res. 1993 Sep 1;53(17):3869–3873. [PubMed] [Google Scholar]
  7. Chuaqui R. F., Sanz-Ortega J., Vocke C., Linehan W. M., Sanz-Esponera J., Zhuang Z., Emmert-Buck M. R., Merino M. J. Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas. Cancer Res. 1995 Nov 1;55(21):4995–4998. [PubMed] [Google Scholar]
  8. Cliby W., Ritland S., Hartmann L., Dodson M., Halling K. C., Keeney G., Podratz K. C., Jenkins R. B. Human epithelial ovarian cancer allelotype. Cancer Res. 1993 May 15;53(10 Suppl):2393–2398. [PubMed] [Google Scholar]
  9. Collins N., McManus R., Wooster R., Mangion J., Seal S., Lakhani S. R., Ormiston W., Daly P. A., Ford D., Easton D. F. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene. 1995 Apr 20;10(8):1673–1675. [PubMed] [Google Scholar]
  10. Connor F., Bertwistle D., Mee P. J., Ross G. M., Swift S., Grigorieva E., Tybulewicz V. L., Ashworth A. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat Genet. 1997 Dec;17(4):423–430. doi: 10.1038/ng1297-423. [DOI] [PubMed] [Google Scholar]
  11. Cunningham C., Dunlop M. G., Wyllie A. H., Bird C. C. Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene. 1993 May;8(5):1391–1396. [PubMed] [Google Scholar]
  12. Eiriksdottir G., Barkardottir R. B., Agnarsson B. A., Johannesdottir G., Olafsdottir K., Egilsson V., Ingvarsson S. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers. Oncogene. 1998 Jan 8;16(1):21–26. doi: 10.1038/sj.onc.1201509. [DOI] [PubMed] [Google Scholar]
  13. Emi M., Fujiwara Y., Nakajima T., Tsuchiya E., Tsuda H., Hirohashi S., Maeda Y., Tsuruta K., Miyaki M., Nakamura Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res. 1992 Oct 1;52(19):5368–5372. [PubMed] [Google Scholar]
  14. Emi M., Fujiwara Y., Ohata H., Tsuda H., Hirohashi S., Koike M., Miyaki M., Monden M., Nakamura Y. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer. 1993 Jul;7(3):152–157. doi: 10.1002/gcc.2870070307. [DOI] [PubMed] [Google Scholar]
  15. Gretarsdottir S., Thorlacius S., Valgardsdottir R., Gudlaugsdottir S., Sigurdsson S., Steinarsdottir M., Jonasson J. G., Anamthawat-Jonsson K., Eyfjörd J. E. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Cancer Res. 1998 Mar 1;58(5):859–862. [PubMed] [Google Scholar]
  16. Gudmundsson J., Johannesdottir G., Bergthorsson J. T., Arason A., Ingvarsson S., Egilsson V., Barkardottir R. B. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res. 1995 Nov 1;55(21):4830–4832. [PubMed] [Google Scholar]
  17. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Généthon human genetic linkage map. Nat Genet. 1994 Jun;7(2 Spec No):246–339. doi: 10.1038/ng0694supp-246. [DOI] [PubMed] [Google Scholar]
  18. Ingvarsson S., Agnarsson B. A., Sigbjornsdottir B. I., Kononen J., Kallioniemi O. P., Barkardottir R. B., Kovatich A. J., Schwarting R., Hauck W. W., Huebner K. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. Cancer Res. 1999 Jun 1;59(11):2682–2689. [PubMed] [Google Scholar]
  19. Ingvarsson S., Geirsdottir E. K., Johannesdottir G., Sigbjörnsdóttir B. I., Eiriksdottir G., Ragnarsson G., Agnarsson B. A., Gudmundsson J., Jonasson J. G., Sigurdsson A. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation. Cancer Res. 1998 Oct 1;58(19):4421–4425. [PubMed] [Google Scholar]
  20. Johannesdottir G., Gudmundsson J., Bergthorsson J. T., Arason A., Agnarsson B. A., Eiriksdottir G., Johannsson O. T., Borg A., Ingvarsson S., Easton D. F. High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res. 1996 Aug 15;56(16):3663–3665. [PubMed] [Google Scholar]
  21. Kerangueven F., Essioux L., Dib A., Noguchi T., Allione F., Geneix J., Longy M., Lidereau R., Eisinger F., Pébusque M. J. Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene. 1995 Mar 2;10(5):1023–1026. [PubMed] [Google Scholar]
  22. Knowles M. A., Shaw M. E., Proctor A. J. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene. 1993 May;8(5):1357–1364. [PubMed] [Google Scholar]
  23. MacGrogan D., Levy A., Bostwick D., Wagner M., Wells D., Bookstein R. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer. 1994 Jul;10(3):151–159. doi: 10.1002/gcc.2870100302. [DOI] [PubMed] [Google Scholar]
  24. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  25. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Newman B., Austin M. A., Lee M., King M. C. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci U S A. 1988 May;85(9):3044–3048. doi: 10.1073/pnas.85.9.3044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ohata H., Emi M., Fujiwara Y., Higashino K., Nakagawa K., Futagami R., Tsuchiya E., Nakamura Y. Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosomes Cancer. 1993 Jun;7(2):85–88. doi: 10.1002/gcc.2870070204. [DOI] [PubMed] [Google Scholar]
  28. Patel K. J., Yu V. P., Lee H., Corcoran A., Thistlethwaite F. C., Evans M. J., Colledge W. H., Friedman L. S., Ponder B. A., Venkitaraman A. R. Involvement of Brca2 in DNA repair. Mol Cell. 1998 Feb;1(3):347–357. doi: 10.1016/s1097-2765(00)80035-0. [DOI] [PubMed] [Google Scholar]
  29. Radford D. M., Fair K. L., Phillips N. J., Ritter J. H., Steinbrueck T., Holt M. S., Donis-Keller H. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res. 1995 Aug 1;55(15):3399–3405. [PubMed] [Google Scholar]
  30. Rajan J. V., Marquis S. T., Gardner H. P., Chodosh L. A. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol. 1997 Apr 15;184(2):385–401. doi: 10.1006/dbio.1997.8526. [DOI] [PubMed] [Google Scholar]
  31. Seitz S., Rohde K., Bender E., Nothnagel A., Kölble K., Schlag P. M., Scherneck S. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families. Oncogene. 1997 Feb 13;14(6):741–743. doi: 10.1038/sj.onc.1200881. [DOI] [PubMed] [Google Scholar]
  32. Seitz S., Rohde K., Bender E., Nothnagel A., Pidde H., Ullrich O. M., El-Zehairy A., Haensch W., Jandrig B., Kölble K. Deletion mapping and linkage analysis provide strong indication for the involvement of the human chromosome region 8p12-p22 in breast carcinogenesis. Br J Cancer. 1997;76(8):983–991. doi: 10.1038/bjc.1997.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Smith S. A., Easton D. F., Evans D. G., Ponder B. A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet. 1992 Oct;2(2):128–131. doi: 10.1038/ng1092-128. [DOI] [PubMed] [Google Scholar]
  34. Thorlacius S., Sigurdsson S., Bjarnadottir H., Olafsdottir G., Jonasson J. G., Tryggvadottir L., Tulinius H., Eyfjörd J. E. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet. 1997 May;60(5):1079–1084. [PMC free article] [PubMed] [Google Scholar]
  35. Tirkkonen M., Johannsson O., Agnarsson B. A., Olsson H., Ingvarsson S., Karhu R., Tanner M., Isola J., Barkardottir R. B., Borg A. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res. 1997 Apr 1;57(7):1222–1227. [PubMed] [Google Scholar]
  36. Tirkkonen M., Kainu T., Loman N., Jóhannsson O. T., Olsson H., Barkardóttir R. B., Kallioniemi O. P., Borg A. Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer. Genes Chromosomes Cancer. 1999 Jan;24(1):56–61. doi: 10.1002/(sici)1098-2264(199901)24:1<56::aid-gcc8>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  37. Vogelstein B., Fearon E. R., Kern S. E., Hamilton S. R., Preisinger A. C., Nakamura Y., White R. Allelotype of colorectal carcinomas. Science. 1989 Apr 14;244(4901):207–211. doi: 10.1126/science.2565047. [DOI] [PubMed] [Google Scholar]
  38. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995 Dec 21;378(6559):789–792. doi: 10.1038/378789a0. [DOI] [PubMed] [Google Scholar]
  39. Wooster R., Neuhausen S. L., Mangion J., Quirk Y., Ford D., Collins N., Nguyen K., Seal S., Tran T., Averill D. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994 Sep 30;265(5181):2088–2090. doi: 10.1126/science.8091231. [DOI] [PubMed] [Google Scholar]
  40. Yaremko M. L., Kutza C., Lyzak J., Mick R., Recant W. M., Westbrook C. A. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer. 1996 Jul;16(3):189–195. doi: 10.1002/(SICI)1098-2264(199607)16:3<189::AID-GCC6>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  41. Yaremko M. L., Recant W. M., Westbrook C. A. Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers. Genes Chromosomes Cancer. 1995 Jul;13(3):186–191. doi: 10.1002/gcc.2870130308. [DOI] [PubMed] [Google Scholar]
  42. Yaremko M. L., Wasylyshyn M. L., Paulus K. L., Michelassi F., Westbrook C. A. Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas. Genes Chromosomes Cancer. 1994 May;10(1):1–6. doi: 10.1002/gcc.2870100102. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES